Michael O’Connell Ph.D.
Dr. Michael J. O’Connell, protégé of the late father of nanotechnology, Richard Smalley, now leads a team of nanotech researchers at Theranos Inc., a firm exploring ways to apply nano-bio techniques to combat adverse drug reactions (ADRs). O'Connell's work focuses on using CNTs and other nano-bio tools to provide real-time insight into how individuals react to prescribed medicines. The goal: to flag ADRs or adverse interactions between multiple drugs immediately, and to help physicians and drug companies improve risk profiles on prescription medicines.
Dr. O’Connell graduated with a B.S. in biochemistry and molecular biology from the
EducationPh.D, Rice University
Career HighlightsDr. O’Connell has numerous patents and publications in the nanotech field.. O’Connell’s many accomplishments include the Director of Central Intelligence Postdoctoral Fellowship from 2003 to 2005. He has been a Los Alamos National Laboratory Director’s Postdoctoral Fellow in 2003, a Los Alamos National Laboratory Postdoctoral Fellow in 2003, a Welch Fellow of Rice University from 2000 to 2002, and a President’s Undergraduate Fellow of the
Dr. O’Connell He wrote “4-centimeter- Long Carbon Nanotubes” for Nanotech Briefs that won the Nano 50 Award in 2005. He was honored with the College Eight Research Award from the University of California–Santa Cruz from 1997 to 1998 and is a member of the Phi Lambda Upsilon Honor Society.
Carbon Nanotubes: Properties and Applications; CRC Press, May 2006
S. K. Doorn, M. J. O'Connell, L. X. Zheng, Y. T. T. Zhu, S. M. Huang, and J. Liu, "Raman spectral imaging of a carbon nanotube intramolecular junction", Physical Review Letters,, 2005, 94(1), Art. No. 016802.
Band Gap Fluorescence from Individual Single-Walled Carbon Nanotubes, Michael J. O'Connell,
By this Researcher